Multiple sclerosis in the real world: A systematic review of fingolimod as a case study

The aim of our study was to systematically review the growing body of published literature reporting on one specific multiple sclerosis (MS) treatment, fingolimod, in the real world to assess its effectiveness in patients with MS, evaluate methodologies used to investigate MS in clinical practice, and describe the evidence gaps for MS as exemplified by fingolimod.We conducted a PRISMA-compliant systematic review of the literature (cut-off date:...